Senior Associate

Sarah Aschenbrenner

Languages
German, English
Consulting focuses
  • Life Sciences
  • Medicinal Products Law
  • Medical device regulation
  • Commercial Contracts
  • Intellectual Property
  • Health Care Compliance
  • Law on Advertising of Medical Products
  • Pflanzenschutzmittelrecht
  • Start-ups
Show moreShow less

Vita

  • Admitted to the bar since 2022
  • Education and former activities
  • Senior Associate at Taylor Wessing in the Life Sciences department 2023-2025
  • Associate at Fieldfisher in the Life Sciences department 2022-2023
  • Legal clerkship at the Munich Higher Regional Court 2019-2021
  • Law studies at Ludwig Maximilian University of Munich 2013-2019

Qualifications/current topics

Sarah Aschenbrenner advises national and international companies in the pharmaceutical, medical device, and biotech industries on all legal matters throughout the entire life cycle of medicinal products and medical devices. Her practice focuses on drafting contracts for the research, development, and marketing of medicinal products and medical devices, as well as providing regulatory and transaction related advice.

Affiliations

  • International Bar Association (IBA)
  • International Association of Young Lawyers (AIJA)
  • European Pharmaceutical Law Association (EPLA) 

Publications

2025

Start of the transition period: EUDAMED use becomes mandatory
Update Health Care & Life Sciences 11/2025,
together with Dr. Stefanie Greifeneder
Standardisierung als Standortfaktor? Standardvertragsklauseln im Arzneimittelrecht
Platform Life Sciences, Biotechnology Edition 2/2025 p. 70 ff,
together with Dr. Manja Epping , Dr. Stefanie Greifeneder

Lectures

2025

Arzneimittelimport und Herstellungserlaubnis
Zentrum für Weiterbildung und Wissenstransfer (ZWW), Drug Regulatory Affairs, University of Augsburg, October 18, 2025
Vertragsgestaltung in den Life Sciences
Workshop der BioM Biotech Cluster Development GmbH, July 23, 2025, Munich,
together with Dr. Stefanie Greifeneder , Dr. Manja Epping

You are currently using an outdated and no longer supported browser (Internet Explorer). To ensure the best user experience and save you from possible problems, we recommend that you use a more modern browser.